Health protection – collection

Mumps: guidance, data and analysis

The symptoms, diagnosis, management, surveillance and epidemiology of mumps.

Mumps is a viral illness caused by a paramyxovirus. Transmission is by direct contact with saliva or droplets from the saliva of an infected person.

Early symptoms include a headache and fever characterised by swelling of the parotid glands which may be one or two sided. Other symptoms include pancreatitis, neuritis, arthritis, mastitis, nephritis, thyroiditis and pericarditis. Mumps is rarely fatal but complications include swelling of the ovaries (oophoritis), swelling of the testes (orchitis), aseptic meningitis and deafness.

Mumps is a notifiable disease in England and Wales.

Mumps is vaccine preventable. In the UK children receive 2 doses of the combined measles mumps rubella (MMR) vaccine as part of the routine childhood immunisation schedule.

For more information about mumps, visit NHS Choices.

Clinical management

  1. Infection control in schools

    • Guidance

Epidemiology

To view older data, view the health protection archive.

  1. Measles, mumps and rubella: laboratory confirmed cases in England 2014

    • Research and analysis
  2. Mumps: confirmed cases

    • Research and analysis
  3. Mumps: notifications by age, region and sex

    • Research and analysis

Vaccination

Immunisation is the most effective way to protect against mumps. Children should receive 2 doses of MMR before the age of 5 years.

In April 2013, Public Health England, NHS England and the Department of Health announced a national catch-up programme to increase MMR vaccination uptake in children and teenagers.

Vaccine uptake data for MMR are available through the Cover of vaccination evaluated rapidly (COVER) programme.

  1. Measles, mumps, rubella (MMR): use of combined vaccine instead of single vaccines

    • Guidance
  2. Mumps: the green book, chapter 23

    • Guidance